Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease
Wenwu Liu, Xin Liu, Wenjie Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114095-114095
Closed Access | Times Cited: 24

Showing 24 citing articles:

Research progress of natural products and their derivatives against Alzheimer’s disease
Jinying Liu, Hongyan Guo, Zhe‐Shan Quan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 21
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease
Wenjie Liu, Limeng Wu, Wenwu Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114689-114689
Closed Access | Times Cited: 33
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer’s Disease
Huanhua Chen, Xudong Gao, Xinzhu Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12571-12600
Closed Access | Times Cited: 5
Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer’s disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation
Esraa Abdo Moustafa, Heba Abdelrasheed Allam, Marwa A. Fouad, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107324-107324
Closed Access | Times Cited: 4
Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects
Zimeng Cheng, Tianyue Han, Jingtong Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116065-116065
Closed Access | Times Cited: 11
Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer’s disease
Junqiu He, Kin Yip Tam
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103914-103914
Closed Access | Times Cited: 4
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment
Wenjie Liu, Liting Tian, Limeng Wu, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106168-106168
Closed Access | Times Cited: 15
Natural products as a source of cholinesterase inhibitors
Pamella Christina Ortega de Oliveira, Gabriel Matias da Silva, Quézia B. Cass, et al.
Pharmacological Research - Natural Products (2024) Vol. 5, pp. 100099-100099
Closed Access | Times Cited: 2
Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
Ning Yan, Xiaolong Shi, Long‐Qian Tang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1724-1736
Open Access | Times Cited: 12
Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer’s Disease
Wu Xiuyuan, Xiaotong Ze, Shuai Qin, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1782-1782
Open Access | Times Cited: 1
Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine
Pankaj Kadyan, Lovedeep Singh
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 665-678
Closed Access | Times Cited: 1
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 1
Designing of new tetrahydro-β-carboline-based ABCG2 inhibitors using 3D-QSAR, molecular docking, and DFT tools
Shahnawaz Ahmad, Dinesh Gupta, Tanzeel Ahmed, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 23, pp. 14016-14027
Closed Access | Times Cited: 4
Comprehensive review of α-carboline alkaloids: Natural products, updated synthesis, and biological activities
Deping Li, Renze Yang, Jun Wu, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 7
Green Stereoselective Synthesis and In Silico Anticancer Evaluation of Tetrahydro-β-carboline-Derived Spiro Heterocycles
Ani Deepthi, Maneesh Mohan, Susan P. Eldhose, et al.
Synthesis (2023) Vol. 55, Iss. 16, pp. 2526-2536
Closed Access | Times Cited: 2
Novel acetylcholinesterase inhibitors: Synthesis, docking and inhibitory activity evaluation of 4-benzamido-N-(1-benzylpiperidin-4-yl) benzamide derivatives
Ahmad Mohammadi-Farani, Sara Nazari, Mahsa Mohammadi, et al.
Results in Chemistry (2023) Vol. 7, pp. 101273-101273
Open Access | Times Cited: 2
Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitors
Yaoguang Huang, Wenwu Liu, Shuoqi Huang, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105870-105870
Closed Access | Times Cited: 4
Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement
Samson Lalhmangaihzuala, Khiangte Vanlaldinpuia, Vanlalngaihawma Khiangte, et al.
Molecular Diversity (2024)
Closed Access
Peganum harmala L. seed extract attenuates anxiety and depression in rats by reducing neuroinflammation and restoring the BDNF/TrkB signaling pathway and monoamines after exposure to chronic unpredictable mild stress
Yasemin Tekşen, Meliha Koldemir Gündüz, Derya Berikten, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 8, pp. 1523-1541
Closed Access
Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer’s disease
Dipanjan Karati, Shreyasi Meur, Souvik Roy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Resource distribution, pharmacological activity, toxicology and clinical drugs of β-Carboline alkaloids: An updated and systematic review
Lili Yu, Na Shen, Jiani Ren, et al.
Fitoterapia (2024) Vol. 180, pp. 106326-106326
Closed Access
β‐Carboline Alkaloids Resist the Aggregation and Cytotoxicity of Human Islet Amyloid Polypeptide
Yanan Wang, Yan Huo, Wang Shao, et al.
ChemBioChem (2023) Vol. 24, Iss. 20
Closed Access | Times Cited: 1
Design, synthesis, molecular docking and biological evaluation of β-carboline derivatives as cholinesterase inhibitors
Paula Baréa, Diego Alberto dos Santos Yamazaki, Diego de Souza Lima, et al.
Journal of Molecular Structure (2022) Vol. 1273, pp. 134291-134291
Closed Access | Times Cited: 1
Discovery of novel and potent tacrine derivatives as CDK2 inhibitors
Yaoguang Huang, Deping Li, Chang Xu, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 43, pp. 20972-20984
Closed Access
Page 1

Scroll to top